Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-011226
Filing Date
2025-08-12
Accepted
2025-08-12 16:15:52
Documents
66
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gbio-20250630x10q.htm   iXBRL 10-Q 1571159
2 EX-10.1 gbio-20250630xex10d1.htm EX-10.1 97969
3 EX-10.2 gbio-20250630xex10d2.htm EX-10.2 50275
4 EX-31.1 gbio-20250630xex31d1.htm EX-31.1 7957
5 EX-31.2 gbio-20250630xex31d2.htm EX-31.2 8501
6 EX-32.1 gbio-20250630xex32d1.htm EX-32.1 4626
7 EX-32.2 gbio-20250630xex32d2.htm EX-32.2 4891
  Complete submission text file 0001558370-25-011226.txt   6579560

Data Files

Seq Description Document Type Size
8 EX-101.SCH gbio-20250630.xsd EX-101.SCH 45883
9 EX-101.CAL gbio-20250630_cal.xml EX-101.CAL 46800
10 EX-101.DEF gbio-20250630_def.xml EX-101.DEF 193397
11 EX-101.LAB gbio-20250630_lab.xml EX-101.LAB 353584
12 EX-101.PRE gbio-20250630_pre.xml EX-101.PRE 308109
69 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20250630x10q_htm.xml XML 1095820
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39319 | Film No.: 251206906
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)